|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|US11077055||DEXCEL PHARMA||Orally disintegrating compositions|| |
(12 years from now)
Lansoprazole is owned by Dexcel Pharma.
Lansoprazole contains Lansoprazole.
Lansoprazole has a total of 1 drug patent out of which 0 drug patents have expired.
Lansoprazole was authorised for market use on 07 June, 2016.
Lansoprazole is available in tablet, orally disintegrating, delayed release;oral dosage forms.
The generics of Lansoprazole are possible to be released after 21 April, 2036.
Market Authorisation Date: 07 June, 2016
Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic